Press Releases

11/02 Hikma Pharmaceuticals : R&D. Innovation in clinical research. Meet Hiba Kamal PU
03/02 Client Update: Supreme Court Takes Up Skinny Labels Granting Certiorari In Hikma v. Amarin AQ
19/01 Hikma announces launch of Enoby and Xtrenbo referencing Prolia and Xgeva respectively AQ
19/01 Hikma Pharmaceuticals : announces launch of Enoby™ (denosumab- qbde) and Xtrenbo™ (denosumab- qbde) referencing Prolia® and Xgeva® respect... PU
15/01 Hikma Pharmaceuticals : achieves B scores in Climate Change and Water Security in 2025 CDP assessment PU
07/01 Hikma Pharmaceuticals : Exploring partnership opportunities with Hikma Pharmaceuticals PU
17/12 Hikma Pharmaceuticals : full year 2025 aide memoire PU
15/12 Hikma Pharmaceuticals : Inspiring women of Hikma - Meet Cristina Cagnazzi, Finance Director, Hikma Italy PU
08/12 European Injectables growth: a Q&A with Nassim Rahmani, Associate VP, Commercial Europe & Canada PU
08/12 Hikma Pharmaceuticals : launches TYZAVAN™ (vancomycin injection, USP) in the US PU
27/11 Hikma Pharmaceuticals : Jefferies London Healthcare Conference Transcript PU
24/11 Hikma Pharmaceuticals : Inspiring women of Hikma - Meet Susana Pereira Sr. Director Quality Systems & Validation – EU & MENA Injectables PU
20/11 Hikma Pharmaceuticals : celebrates 20 years on the London Stock Exchange PU
19/11 Strategic Priorities in Hikma Pharmaceuticals R&D: Q&A with Hafrun Fridriksdottir, EVP, Rx and R&D PU
11/11 Hikma Launches Ustekinumab Biosimilar STARJEMZA AQ
10/11 Hikma Pharmaceuticals : R&D. Innovating Formulation Development. Meet Razan Alsawwaf PU
06/11 Hikma Pharmaceuticals : November 2025 Trading Update PU
06/11 Hikma Pharmaceuticals : announces the launch of STARJEMZA™ (ustekinumab-hmny) Injection, a biosimilar referencing STELARA®... PU
23/25/23 Hikma Pharmaceuticals : R&D. Innovating analytical development. Meet Edvin Brusač PU
23/25/23 Hikma Pharmaceuticals : R&D. Innovating formulation development. Meet Edvin Brusač PU
15/25/15 Hikma Pharmaceuticals : R&D. Innovating formulation development. Meet Anas Abdull-kareem Younues PU
06/25/06 Hikma Pharmaceuticals : and Celltrion strengthen partnership to expand biosimilar access in MENA PU
03/25/03 Driving pharmaceutical excellence and growth in Pavia: A Q&A with Roberto Gagliano, General Manager, Hikma Italia PU
29/25/29 Hikma Pharmaceuticals : R&D Innovating formulation development. Meet Helena Sremec PU
29/25/29 Hikma Pharmaceuticals : and Richter receive FDA approval for denosumab biosimilars EnobyTM (denosumab- qbde) and XtrenboTM (denosumab- qbd... PU
No results for this search